Dear Friend of Drugreporter!
the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) is a Lisbon-based institute that aims to provide reliable information on drugs. It has a central role in evidence-based decision making – even if decision makers often ignore the evidence EMCDDA provides. We interviewed EMCDDA’s new director, Alexis Goodseel, who explained what are the new trends in the drug market in Europe and how his agency is trying to adapt to the new economic and political environment. Please read and share this interivew!
When we visited Australia to attend the International AIDS Conference last year, we created a lot of footage we couldn’t edit immediately because of other work. This summer, we had some time to work on this footage, and produced three videos highlighting different aspects of harm reduction in Australia. We do not only recommend to watch these videos to those who are interested in Australian drug policy – but to everybody who would like to learn about harm reduction in general!
Legalisation of Medicinal Cannabis in Macedonia
In February 2016, Macedonia legalised medicinal cannabis but the law is far from ideal. Drugreporter’s Macedonian partner, Healthy Options Project Skopje – HOPS – carried out an analysis of the law. Read their key remarks and recommendations presented by Vlatko Dekov.
The Baltic Trip Trilogy
Watch three short videos produced by Drug User News at Drugreporter, about the state of drug policy and harm reduction in Lithuania, Latvia, and Estonia.
Subscribe to our videos on:
